Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis.

Saleh, Ramy R; Peinado, Paloma; Fuentes-Antrás, Jesús; Pérez-Segura, Pedro; Pandiella, Atanasio; Amir, Eitan; Ocaña, Alberto.

Afiliação

Saleh RR; Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Peinado P; Experimental Therapeutics Unit, Medical Oncology Department, Hospital Clínico San Carlos, and IdISSC, Madrid, Spain.
Fuentes-Antrás J; Experimental Therapeutics Unit, Medical Oncology Department, Hospital Clínico San Carlos, and IdISSC, Madrid, Spain.
Pérez-Segura P; Experimental Therapeutics Unit, Medical Oncology Department, Hospital Clínico San Carlos, and IdISSC, Madrid, Spain.
Pandiella A; Centro de Investigación del Cáncer-CSIC, Salamanca, Spain.
Amir E; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.
Ocaña A; Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

Front Oncol ; 9: 1040, 2019.

Article em En | MEDLINE | ID: mdl-31681578